Persistent depressive disorder

The UK National Institute for Health and Care Excellence (NICE) advice is to follow up between 2 and 4 weeks of antidepressant initiation or dose change, unless there is suicidal ideation in which case 1 week. There is additional specific advice from the committee longer term e.g. at least yearly review for people on longer term antidepressants.[37]National Institute for Health and Care Excellence. Depression in adults: treatment and management. June 2022 [internet publication]. https://www.nice.org.uk/guidance/ng222 Once patients have achieved remission of symptoms they could be monitored monthly, or even less frequently depending on the individual circumstances. Self-rated scales for depression monitoring are recommended. These include the Patient Health Questionnaire (PHQ-9), the Beck Depression Inventory (BDI), and the Quick Inventory of Depressive Symptoms (QIDS).[34]Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001 Sep;16(9):606-13. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1495268 http://www.ncbi.nlm.nih.gov/pubmed/11556941?tool=bestpractice.com [35]Beck AT, Ward CH, Mendelson M, et al. An inventory for measuring depression. Arch Gen Psychiatry. 1961 Jun;4:561-71. http://www.ncbi.nlm.nih.gov/pubmed/13688369?tool=bestpractice.com [36]Trivedi MH, Rush AJ, Ibrahim HM, et al. The Inventory of Depressive Symptomatology, Clinician Rating (IDS-C) and Self-Report (IDS-SR), and the Quick Inventory of Depressive Symptomatology, Clinician Rating (QIDS-C) and Self-Report (QIDS-SR) in public sector patients with mood disorders: a psychometric evaluation. Psychol Med. 2004 Jan;34(1):73-82. http://www.ncbi.nlm.nih.gov/pubmed/14971628?tool=bestpractice.com